CRISPR Therapeutics Ownership 2024 | Who Owns CRISPR Therapeutics Now?
Institutional Ownership
27.33%
Insider Ownership
1.74%
Retail Ownership
70.93%
Institutional Holders
267.00
CRISPR Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAPITAL INTERNATIONAL INVESTORS | 9.62% | 0.09% | 7,865,253 | 28,179 | 0.36% | 424,802,315 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 9.51% | 3.73% | 7,778,536 | -378,492 | -4.64% | 420,118,712 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 3.85% | 0.13% | 3,151,514 | -117,271 | -3.59% | 170,213,271 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.85% | 1.96% | 3,151,514 | -117,271 | -3.59% | 169,992,665 | Jun 30, 2024 |
| BLACKROCK INC. | 3.40% | 0.00% | 2,777,784 | 231,423 | 9.09% | 150,028,114 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 3.34% | 0.09% | 2,730,652 | 26,321 | 0.97% | 147,483,000 | Jun 30, 2024 |
| STATE STREET CORP | 2.93% | 0.01% | 2,393,684 | 898,476 | 60.09% | 129,282,873,000 | Jun 30, 2024 |
| FMR LLC | 2.88% | 0.01% | 2,353,091 | 113,408 | 5.06% | 127,090,442 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.14% | 0.00% | 1,748,513 | 111,714 | 6.83% | 94,437,187 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 1.94% | 6.45% | 1,587,854 | - | - | 85,759,995 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 1.70% | 2.30% | 1,389,276 | - | - | 75,034,797 | Jun 30, 2024 |
| SR ONE CAPITAL MANAGEMENT, LP | 1.28% | 17.74% | 1,048,951 | - | - | 56,653,844 | Jun 30, 2024 |
| LOOMIS SAYLES & CO L P | 1.23% | 0.07% | 1,006,213 | -19,030 | -1.86% | 54,346,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.19% | 0.00% | 973,018 | 63,720 | 7.01% | 52,573,514 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.16% | 0.01% | 950,149 | 19,094 | 2.05% | 51,326,008 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.15% | 0.00% | 941,550 | 78,336 | 9.07% | 50,853,116 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.88% | 0.01% | 717,606 | 48,414 | 7.23% | 38,757,900 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.85% | 0.01% | 693,958 | 583,493 | 528.22% | 37,480,673 | Jun 30, 2024 |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 0.84% | 2.32% | 685,716 | 19,716 | 2.96% | 37,036,000 | Jun 30, 2024 |
| NORGES BANK | 0.79% | 0.01% | 650,208 | 650,208 | 100.00% | 35,117,734 | Jun 30, 2024 |
CRISPR Therapeutics's largest institutional shareholder is CAPITAL INTERNATIONAL INVESTORS, holding 9.62% of the company's total share outstanding, currently valued at $424.80M. The top 10 institutional shareholders own together 43.45% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VERSANT VENTURE MANAGEMENT, LLC | 0.61% | 34.84% | 498,558 | - | - | 26,927,118 | Jun 30, 2024 |
| SR ONE CAPITAL MANAGEMENT, LP | 1.28% | 17.74% | 1,048,951 | - | - | 56,653,844 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 1.94% | 6.45% | 1,587,854 | - | - | 85,759,995 | Jun 30, 2024 |
| SPEAR HOLDINGS RSC LTD | 0.20% | 6.29% | 165,000 | - | - | 8,911,650 | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 9.51% | 3.73% | 7,778,536 | -378,492 | -4.64% | 420,118,712 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.25% | 3.29% | 201,497 | 81,312 | 67.66% | 10,882,853 | Jun 30, 2024 |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 0.84% | 2.32% | 685,716 | 19,716 | 2.96% | 37,036,000 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 1.70% | 2.30% | 1,389,276 | - | - | 75,034,797 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.85% | 1.96% | 3,151,514 | -117,271 | -3.59% | 169,992,665 | Jun 30, 2024 |
| EAGLE HEALTH INVESTMENTS LP | 0.24% | 1.87% | 197,000 | - | - | 10,639,970 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.39% | 1.74% | 316,500 | 200,000 | 171.67% | 17,094,165 | Jun 30, 2024 |
| DEL-SETTE CAPITAL MANAGEMENT, LLC | 0.04% | 1.63% | 36,841 | 36,841 | 100.00% | 1,989,782 | Jun 30, 2024 |
| BAKER CHAD R | 0.12% | 1.11% | 98,520 | - | - | 5,321,065 | Jun 30, 2024 |
| GREEN ALPHA ADVISORS, LLC | 0.02% | 0.85% | 19,637 | -7,319 | -27.15% | 1,060,594 | Jun 30, 2024 |
| HEDGES ASSET MANAGEMENT LLC | 0.03% | 0.85% | 21,800 | 2,425 | 12.52% | 1,177,419 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.18% | 0.77% | 150,000 | -70,000 | -31.82% | 8,101,500 | Jun 30, 2024 |
| SLOW CAPITAL, INC. | 0.10% | 0.69% | 79,216 | 11,647 | 17.24% | 4,278,457 | Jun 30, 2024 |
| FARROW FINANCIAL INC. | 0.02% | 0.64% | 17,360 | 341 | 2.00% | 937,614 | Jun 30, 2024 |
| SHARIAPORTFOLIO, INC. | 0.03% | 0.62% | 21,404 | 21,404 | 100.00% | 1,155,995 | Jun 30, 2024 |
| WEST FAMILY INVESTMENTS, INC. | 0.04% | 0.57% | 35,500 | - | - | 1,917,355 | Jun 30, 2024 |
The largest CRISPR Therapeutics shareholder by % of total assets is VERSANT VENTURE MANAGEMENT, LLC. The company owns 498.56K shares of CRISPR Therapeutics (CRSP), representing 34.84% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 2.93% | 0.01% | 2,393,684 | 898,476 | 60.09% | 129,282,873,000 | Jun 30, 2024 |
| NORGES BANK | 0.79% | 0.01% | 650,208 | 650,208 | 100.00% | 35,117,734 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.85% | 0.01% | 693,958 | 583,493 | 528.22% | 37,480,673 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.65% | 0.14% | 530,000 | 530,000 | 100.00% | 28,625,300 | Jun 30, 2024 |
| BLACKROCK INC. | 3.40% | 0.00% | 2,777,784 | 231,423 | 9.09% | 150,028,114 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.39% | 1.74% | 316,500 | 200,000 | 171.67% | 17,094,165 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.23% | 0.01% | 186,591 | 186,591 | 100.00% | 10,077,780 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.18% | 0.16% | 146,473 | 146,473 | 100.00% | 7,911,007 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.32% | 0.00% | 265,347 | 132,650 | 99.96% | 14,331,392 | Jun 30, 2024 |
| FMR LLC | 2.88% | 0.01% | 2,353,091 | 113,408 | 5.06% | 127,090,442 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.14% | 0.00% | 1,748,513 | 111,714 | 6.83% | 94,437,187 | Jun 30, 2024 |
| UBS GROUP AG | 0.52% | 0.01% | 424,216 | 103,839 | 32.41% | 22,911,905 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 0.12% | 0.07% | 100,000 | 100,000 | 100.00% | 5,401,000 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.11% | 0.01% | 90,664 | 90,664 | 100.00% | 4,896,763 | Jun 30, 2024 |
| BARCLAYS PLC | 0.14% | 0.00% | 114,000 | 87,000 | 322.22% | 6,157,000 | Jun 30, 2024 |
| HANDELSBANKEN FONDER AB | 0.12% | 0.02% | 100,300 | 83,600 | 500.60% | 5,417,000 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.25% | 3.29% | 201,497 | 81,312 | 67.66% | 10,882,853 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.15% | 0.00% | 941,550 | 78,336 | 9.07% | 50,853,116 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.09% | 0.01% | 77,018 | 77,018 | 100.00% | 4,169,249 | Jun 30, 2024 |
| PRIVATE ADVISOR GROUP, LLC | 0.09% | 0.03% | 77,627 | 64,076 | 472.85% | 4,192,740 | Jun 30, 2024 |
As of Jun 30 2024, CRISPR Therapeutics's largest institutional buyer is STATE STREET CORP. The company purchased 898.48K stocks of CRSP, valued at $129.28B.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 0.73% | 0.00% | 597,679 | -488,245 | -44.96% | 32,280,685 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | - | - | - | -419,580 | -100.00% | - | Jun 30, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 9.51% | 3.73% | 7,778,536 | -378,492 | -4.64% | 420,118,712 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.17% | 0.11% | 135,000 | -250,000 | -64.94% | 7,291,350 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.07% | 0.05% | 55,000 | -240,000 | -81.36% | 2,970,550 | Jun 30, 2024 |
| BARCLAYS PLC | 0.08% | 0.00% | 65,620 | -190,711 | -74.40% | 3,544,000 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.51% | 0.00% | 420,695 | -179,539 | -29.91% | 22,722,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 2,535 | -164,011 | -98.48% | 140,388 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.08% | 0.00% | 66,600 | -151,900 | -69.52% | 3,597,066 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.03% | 0.00% | 28,174 | -146,121 | -83.84% | 1,521,677 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.23% | 0.01% | 190,408 | -130,115 | -40.59% | 10,283,936 | Jun 30, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.85% | 1.96% | 3,151,514 | -117,271 | -3.59% | 169,992,665 | Jun 30, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 3.85% | 0.13% | 3,151,514 | -117,271 | -3.59% | 170,213,271 | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -109,991 | -100.00% | - | Jun 30, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | 0.10% | 0.01% | 85,400 | -103,100 | -54.70% | 4,612,454 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.23% | 0.03% | 185,800 | -102,300 | -35.51% | 10,035,058 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.03% | 0.00% | 26,326 | -79,317 | -75.08% | 1,421,867 | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.18% | 0.77% | 150,000 | -70,000 | -31.82% | 8,101,500 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -69,429 | -100.00% | - | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -65,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, CRISPR Therapeutics's biggest institutional seller is MORGAN STANLEY. The company sold -0.49M shares of CRSP, valued at $32.28M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 0.79% | 0.01% | 650,208 | 650,208 | 100.00% | 35,117,734 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.65% | 0.14% | 530,000 | 530,000 | 100.00% | 28,625,300 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.18% | 0.16% | 146,473 | 146,473 | 100.00% | 7,911,007 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 0.12% | 0.07% | 100,000 | 100,000 | 100.00% | 5,401,000 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.11% | 0.01% | 90,664 | 90,664 | 100.00% | 4,896,763 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.09% | 0.01% | 77,018 | 77,018 | 100.00% | 4,169,249 | Jun 30, 2024 |
| DEL-SETTE CAPITAL MANAGEMENT, LLC | 0.04% | 1.63% | 36,841 | 36,841 | 100.00% | 1,989,782 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.04% | 0.01% | 28,600 | 28,600 | 100.00% | 1,544,686 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.03% | 0.00% | 26,865 | 26,865 | 100.00% | 1,449,098 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.03% | 0.02% | 24,139 | 24,139 | 100.00% | 1,303,747 | Jun 30, 2024 |
| SHARIAPORTFOLIO, INC. | 0.03% | 0.62% | 21,404 | 21,404 | 100.00% | 1,155,995 | Jun 30, 2024 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 0.02% | 0.02% | 15,918 | 15,918 | 100.00% | 859,734 | Jun 30, 2024 |
| STRATEGIC FINANCIAL CONCEPTS, LLC | 0.02% | 0.00% | 14,836 | 14,836 | 100.00% | 263,000 | Jun 30, 2024 |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 0.01% | 0.05% | 8,708 | 8,708 | 100.00% | 470,319 | Jun 30, 2024 |
| MIRAE ASSET SECURITIES (USA) INC. | 0.01% | 0.02% | 7,534 | 7,534 | 100.00% | 406,911 | Jun 30, 2024 |
| MIRAE ASSET SECURITIES (USA) INC. | 0.01% | 0.02% | 7,500 | 7,500 | 100.00% | 405,075 | Jun 30, 2024 |
| LEVIN CAPITAL STRATEGIES, L.P. | 0.01% | 0.04% | 6,942 | 6,942 | 100.00% | 374,937 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.01% | 0.01% | 5,309 | 5,309 | 100.00% | 286,739 | Jun 30, 2024 |
| TRILOGY CAPITAL INC. | 0.01% | 0.01% | 4,900 | 4,900 | 100.00% | 264,649 | Jun 30, 2024 |
| CHOREO, LLC | 0.00% | 0.00% | 4,047 | 4,047 | 100.00% | 218,336 | Jun 30, 2024 |
| COLONY GROUP, LLC | 0.00% | 0.00% | 3,973 | 3,973 | 100.00% | 215,000 | Jun 30, 2024 |
| SIGMA PLANNING CORP | 0.00% | 0.01% | 3,861 | 3,861 | 100.00% | 208,515 | Jun 30, 2024 |
| 180 WEALTH ADVISORS, LLC | 0.00% | 0.03% | 3,701 | 3,701 | 100.00% | 210,254 | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | 0.00% | 0.02% | 3,440 | 3,440 | 100.00% | 185,794 | Jun 30, 2024 |
| ONE RIVER ASSET MANAGEMENT, LLC | 0.00% | 0.01% | 2,200 | 2,200 | 100.00% | 118,822 | Jun 30, 2024 |
| ONE RIVER ASSET MANAGEMENT, LLC | 0.00% | 0.01% | 1,900 | 1,900 | 100.00% | 102,619 | Jun 30, 2024 |
| THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. | 0.00% | 0.02% | 1,346 | 1,346 | 100.00% | 72,692 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.05% | 1,165 | 1,165 | 100.00% | 62,922 | Jun 30, 2024 |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 0.00% | 0.00% | 1,000 | 1,000 | 100.00% | 54,010 | Jun 30, 2024 |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 0.00% | 0.04% | 1,000 | 1,000 | 100.00% | 54,000 | Jun 30, 2024 |
| EDGEROCK CAPITAL LLC | 0.00% | 0.04% | 850 | 850 | 100.00% | 45,908 | Jun 30, 2024 |
| VISTA PRIVATE WEALTH PARTNERS. LLC | 0.00% | 0.02% | 838 | 838 | 100.00% | 45,261 | Jun 30, 2024 |
| INTERCHANGE CAPITAL PARTNERS, LLC | 0.00% | 0.01% | 600 | 600 | 100.00% | 32,406 | Jun 30, 2024 |
| BOGART WEALTH, LLC | 0.00% | 0.00% | 500 | 500 | 100.00% | 27,005 | Jun 30, 2024 |
| UNIQUE WEALTH STRATEGIES, LLC | 0.00% | 0.01% | 410 | 410 | 100.00% | 27,946 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 250 | 250 | 100.00% | 13,503 | Jun 30, 2024 |
| 0.00% | 0.01% | 208 | 208 | 100.00% | 13,052 | Jun 30, 2024 | |
| OPAL WEALTH ADVISORS, LLC | 0.00% | 0.00% | 200 | 200 | 100.00% | 10,802 | Jun 30, 2024 |
| SOUTHSTATE CORP | 0.00% | 0.00% | 125 | 125 | 100.00% | 6,751 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.00% | 0.00% | 90 | 90 | 100.00% | 486,090 | Jun 30, 2024 |
| TRUST CO OF VERMONT | 0.00% | 0.00% | 85 | 85 | 100.00% | 4,591 | Jun 30, 2024 |
| ORG PARTNERS LLC | - | 0.00% | 15 | 15 | 100.00% | 809,000 | Jun 30, 2024 |
| CAPE INVESTMENT ADVISORY, INC. | - | 0.00% | 15 | 15 | 100.00% | 810 | Jun 30, 2024 |
| RIDGEWOOD INVESTMENTS LLC | - | 0.00% | 15 | 15 | 100.00% | 810 | Jun 30, 2024 |
| BALDWIN BROTHERS LLC/MA | - | - | 4 | 4 | 100.00% | 216 | Jun 30, 2024 |
| MV CAPITAL MANAGEMENT, INC. | - | - | 3 | 3 | 100.00% | 163 | Jun 30, 2024 |
| JNBA FINANCIAL ADVISORS | - | - | 2 | 2 | 100.00% | 109 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | - | - | 1 | 1 | 100.00% | 55 | Jun 30, 2024 |
CRISPR Therapeutics's largest new institutional shareholder by number of shares is NORGES BANK, purchased 650.21K shares, valued at $35.12M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | - | - | - | -419,580 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -109,991 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -69,429 | -100.00% | - | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -65,000 | -100.00% | - | Jun 30, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | - | - | - | -56,114 | -100.00% | - | Jun 30, 2024 |
| SHELLBACK CAPITAL, LP | - | - | - | -50,958 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -49,787 | -100.00% | - | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | - | - | - | -48,000 | -100.00% | - | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -44,312 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -40,700 | -100.00% | - | Jun 30, 2024 |
| IMC-CHICAGO, LLC | - | - | - | -36,722 | -100.00% | - | Jun 30, 2024 |
| BAIRD FINANCIAL GROUP, INC. | - | - | - | -29,575 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -27,678 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -23,503 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -21,790 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -20,400 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -16,682 | -100.00% | - | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | - | - | - | -16,100 | -100.00% | - | Jun 30, 2024 |
| SIGNAL ADVISORS WEALTH, LLC | - | - | - | -14,791 | -100.00% | - | Jun 30, 2024 |
| FOGUTH WEALTH MANAGEMENT, LLC. | - | - | - | -14,791 | -100.00% | - | Jun 30, 2024 |
| SEVEN EIGHT CAPITAL, LP | - | - | - | -12,524 | -100.00% | - | Jun 30, 2024 |
| LEGACY CAPITAL GROUP CALIFORNIA, INC. | - | - | - | -12,318 | -100.00% | - | Jun 30, 2024 |
| BLACKSTONE INC. | - | - | - | -12,196 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -8,918 | -100.00% | - | Jun 30, 2024 |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | - | - | - | -8,856 | -100.00% | - | Jun 30, 2024 |
| LINCOLN NATIONAL CORP | - | - | - | -8,618 | -100.00% | - | Jun 30, 2024 |
| CAPITAL IMPACT ADVISORS, LLC | - | - | - | -7,605 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -7,500 | -100.00% | - | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | - | - | - | -6,656 | -100.00% | - | Jun 30, 2024 |
| CMC FINANCIAL GROUP | - | - | - | -6,623 | -100.00% | - | Jun 30, 2024 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | - | - | - | -6,576 | -100.00% | - | Jun 30, 2024 |
| BEACON POINTE ADVISORS, LLC | - | - | - | -6,334 | -100.00% | - | Jun 30, 2024 |
| YIHENG CAPITAL MANAGEMENT, L.P. | - | - | - | -6,300 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -6,179 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -5,599 | -100.00% | - | Jun 30, 2024 |
| PINNACLE ASSOCIATES LTD | - | - | - | -5,303 | -100.00% | - | Jun 30, 2024 |
| CYNDEO WEALTH PARTNERS, LLC | - | - | - | -5,275 | -100.00% | - | Jun 30, 2024 |
| EQUITABLE HOLDINGS, INC. | - | - | - | -4,853 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -4,439 | -100.00% | - | Jun 30, 2024 |
| SEAVIEW INVESTMENT MANAGERS LLC | - | - | - | -4,400 | -100.00% | - | Jun 30, 2024 |
| WEALTHCARE ADVISORY PARTNERS LLC | - | - | - | -4,200 | -100.00% | - | Jun 30, 2024 |
| HARTLINE INVESTMENT CORP/ | - | - | - | -4,175 | -100.00% | - | Jun 30, 2024 |
| HB WEALTH MANAGEMENT, LLC | - | - | - | -4,101 | -100.00% | - | Jun 30, 2024 |
| KINGSWOOD WEALTH ADVISORS, LLC | - | - | - | -3,914 | -100.00% | - | Jun 30, 2024 |
| LIDO ADVISORS, LLC | - | - | - | -3,816 | -100.00% | - | Jun 30, 2024 |
| CHOATE INVESTMENT ADVISORS | - | - | - | -3,654 | -100.00% | - | Jun 30, 2024 |
| FREESTONE CAPITAL HOLDINGS, LLC | - | - | - | -3,628 | -100.00% | - | Jun 30, 2024 |
| TRAJAN WEALTH LLC | - | - | - | -3,572 | -100.00% | - | Jun 30, 2024 |
| JFG WEALTH MANAGEMENT, LLC | - | - | - | -3,510 | -100.00% | - | Jun 30, 2024 |
| PRIME CAPITAL INVESTMENT ADVISORS, LLC | - | - | - | -3,499 | -100.00% | - | Jun 30, 2024 |
| STAPP WEALTH MANAGEMENT, PLLC | - | - | - | -3,453 | -100.00% | - | Jun 30, 2024 |
| SEACREST WEALTH MANAGEMENT, LLC | - | - | - | -3,364 | -100.00% | - | Jun 30, 2024 |
| AXA S.A. | - | - | - | -3,359 | -100.00% | - | Jun 30, 2024 |
| EVOKE WEALTH, LLC | - | - | - | -3,300 | -100.00% | - | Jun 30, 2024 |
| SHEAFF BROCK INVESTMENT ADVISORS, LLC | - | - | - | -3,127 | -100.00% | - | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | - | - | - | -3,126 | -100.00% | - | Jun 30, 2024 |
| ADVISOR OS, LLC | - | - | - | -3,117 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -3,100 | -100.00% | - | Jun 30, 2024 |
| THRIVE WEALTH MANAGEMENT, LLC | - | - | - | -3,100 | -100.00% | - | Jun 30, 2024 |
| LINCOLN CAPITAL CORP | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| MIRADOR CAPITAL PARTNERS LP | - | - | - | -2,980 | -100.00% | - | Jun 30, 2024 |
| SFG WEALTH MANAGEMENT, LLC. | - | - | - | -2,972 | -100.00% | - | Jun 30, 2024 |
| PROSPERITY CONSULTING GROUP, LLC | - | - | - | -2,966 | -100.00% | - | Jun 30, 2024 |
| MOORS & CABOT, INC. | - | - | - | -2,963 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -1,303 | -100.00% | - | Jun 30, 2024 |
| TUCKER ASSET MANAGEMENT LLC | - | - | - | -1,114 | -100.00% | - | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | - | - | - | -885 | -100.00% | - | Jun 30, 2024 |
| JFS WEALTH ADVISORS, LLC | - | - | - | -782 | -100.00% | - | Jun 30, 2024 |
| VIMA LLC | - | - | - | -518 | -100.00% | - | Jun 30, 2024 |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | - | - | - | -300 | -100.00% | - | Jun 30, 2024 |
| WEBSTER BANK, N. A. | - | - | - | -140 | -100.00% | - | Jun 30, 2024 |
| GOODWIN INVESTMENT ADVISORY | - | - | - | -135 | -100.00% | - | Jun 30, 2024 |
| BANK JULIUS BAER & CO. LTD, ZURICH | - | - | - | -130 | -100.00% | - | Jun 30, 2024 |
| MACROVIEW INVESTMENT MANAGEMENT LLC | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| RALEIGH CAPITAL MANAGEMENT INC. | - | - | - | -50 | -100.00% | - | Jun 30, 2024 |
| GODSEY & GIBB, INC | - | - | - | -45 | -100.00% | - | Jun 30, 2024 |
| PLANTE MORAN FINANCIAL ADVISORS, LLC | - | - | - | -39 | -100.00% | - | Jun 30, 2024 |
| MCF ADVISORS LLC | - | - | - | -20 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
| IMPACT PARTNERSHIP WEALTH, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
CRISPR Therapeutics's largest sold out institutional shareholder by shares sold is AVORO CAPITAL ADVISORS LLC, sold -0.42M shares, valued at -, as of undefined.
CRISPR Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Alger ETF Trust | 0.64% | 4,573 | - | - | Dec 31, 2023 |
| Clough Funds Trust | 0.29% | 12,181 | -600 | -4.69% | Jan 31, 2023 |
| Kelly Strategic ETF Trust | 0.26% | 7,140 | - | - | Feb 29, 2024 |
| Clough Global Equity Fund | 0.25% | 15,710 | - | - | Jan 31, 2024 |
| EntrepreneurShares Series Trust | 0.15% | 40,552 | 33,333 | 461.74% | Dec 31, 2023 |
| FlowStone Opportunity Fund | 0.13% | 700,076 | - | - | Mar 31, 2024 |
| NEW PERSPECTIVE FUND | 0.10% | 3,101,795 | - | - | Mar 31, 2024 |
| NEW ECONOMY FUND | 0.09% | 409,000 | - | - | Feb 29, 2024 |
| SHELTON FUNDS | 0.08% | 131,850 | - | - | Feb 29, 2024 |
| Clough Global Opportunities Fund | 0.07% | 28,151 | - | - | Jan 31, 2024 |
| Absolute Shares Trust | 0.07% | 26,761 | - | - | Mar 31, 2024 |
| NUVEEN INVESTMENT TRUST II | 0.06% | 101,266 | - | - | Mar 31, 2024 |
| RMB INVESTORS TRUST | 0.05% | 28,743 | - | - | Dec 31, 2023 |
| WANGER ADVISORS TRUST | 0.05% | 29,869 | - | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.05% | 165,803 | - | - | Mar 31, 2024 |
| REYNOLDS FUNDS INC | 0.04% | 500 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.04% | 332,628 | - | - | Jan 31, 2024 |
| GROWTH FUND OF AMERICA | 0.03% | 801,620 | - | - | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.03% | 322,408 | - | - | Jan 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.02% | 10,927 | - | - | Mar 31, 2024 |
| ARCHER INVESTMENT SERIES TRUST | 0.01% | 4,500 | - | - | Feb 29, 2024 |
| Jacob Funds Inc. | 0.01% | 2,642 | - | - | Feb 29, 2024 |
| ALGER FUNDS | 0.01% | 11,000 | - | - | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 746,299 | - | - | Mar 31, 2024 |
| ARCHER INVESTMENT SERIES TRUST | 0.01% | 3,100 | - | - | Feb 29, 2024 |
| Collaborative Investment Series Trust | 0.01% | 1,384 | - | - | Mar 31, 2024 |
| AIM FUNDS GROUP (INVESCO FUNDS GROUP) | 0.01% | 38,706 | - | - | Mar 31, 2024 |
| EUROPACIFIC GROWTH FUND | 0.01% | 472,172 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 49,311 | - | - | Feb 29, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.00% | 21,005 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 27,262 | -11,267 | -29.24% | Jan 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 22,381 | -306 | -1.35% | Jan 31, 2024 |
| TOCQUEVILLE TRUST | 0.00% | 500 | - | - | Jan 31, 2024 |
| KINETICS PORTFOLIOS TRUST | 0.00% | 6,000 | - | - | Mar 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 41,613 | -17,224 | -29.27% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,189,400 | -1,171,498 | -49.62% | Mar 31, 2024 |
| NEEDHAM FUNDS INC | 0.00% | 5,500 | - | - | Mar 31, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.00% | 9,300 | - | - | Dec 31, 2023 |
| FORUM FUNDS | 0.00% | 4,440 | - | - | Jan 31, 2024 |
| Global X Funds | 0.00% | 81,993 | - | - | Jan 31, 2024 |
| Capitol Series Trust | 0.00% | 18,000 | - | - | Jan 31, 2024 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.00% | 813 | 176 | 27.63% | Sep 30, 2020 |
| WILLIAMSBURG INVESTMENT TRUST | 0.00% | 4,000 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 30,661 | 2,218 | 7.80% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 272,338 | 3,297 | 1.23% | Feb 29, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 10,328 | - | - | Dec 31, 2023 |
| NORTHERN LIGHTS FUND TRUST III | 0.00% | 12,000 | - | - | Jan 31, 2024 |
| Listed Funds Trust | 0.00% | 4,801 | - | - | Mar 31, 2024 |
| Destra Investment Trust | 0.00% | 1,599 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 141,475 | -9,719 | -6.43% | Jan 31, 2024 |
| TIMOTHY PLAN | 0.00% | 3,782 | - | - | Mar 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 464 | - | - | Sep 30, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 66,889 | - | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 46,466 | 1,862 | 4.17% | Jan 31, 2024 |
| ProFunds | 0.00% | 5,899 | -1,898 | -24.34% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 10,746 | - | - | Jan 31, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 19,703 | - | - | Mar 31, 2024 |
| KP Funds | 0.00% | 21,228 | -12,788 | -37.59% | Sep 30, 2020 |
| BERKSHIRE FUNDS | 0.00% | 10 | - | - | Mar 31, 2024 |
| AMERICAN PENSION INVESTORS TRUST | 0.00% | 1,890 | - | - | Jan 31, 2024 |
| ALLSPRING FUNDS TRUST | 0.00% | 124,479 | - | - | Jan 31, 2024 |
| ADVISORS SERIES TRUST | 0.00% | 9,610 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 174,105 | -11,076 | -5.98% | Dec 31, 2023 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 2,582 | - | - | Mar 31, 2024 |
| Dunham Funds | 0.00% | 10,910 | - | - | Jan 31, 2024 |
| Mutual Fund & Variable Insurance Trust | 0.00% | 2,800 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 15,650 | 2,282 | 17.07% | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 7,513 | 514 | 7.34% | Dec 31, 2023 |
| SATURNA INVESTMENT TRUST | 0.00% | 10,700 | - | - | Feb 29, 2024 |
| Franklin Custodian Funds | 0.00% | 50,000 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 12,878 | - | - | Mar 28, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 6,988 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY VARIABLE PORTFOLIOS INC | 0.00% | 144 | - | - | Mar 31, 2024 |
| Putnam ETF Trust | 0.00% | 468 | 468 | - | Jan 31, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 59,638 | -7,874 | -11.66% | Mar 31, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 4,120 | - | - | Mar 28, 2024 |
| AMERICAN FUNDS INSURANCE SERIES | 0.00% | 262,678 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 3,690 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 37,572 | - | - | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 1,694 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND III | 0.00% | 97,849 | - | - | Jan 31, 2024 |
| VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00% | 42,696 | -708 | -1.63% | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 4,382 | - | - | Jan 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 76,410 | - | - | Feb 29, 2024 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 8,213 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 410 | - | - | Mar 31, 2024 |
| Amplify ETF Trust | 0.00% | 368 | - | - | Mar 31, 2024 |
| Two Roads Shared Trust | 0.00% | 391 | - | - | Jan 31, 2024 |
| Symmetry Panoramic Trust | 0.00% | 379 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 1,618 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 2,130 | 743 | 53.57% | Feb 29, 2024 |
| Northern Lights Fund Trust IV | 0.00% | 2,050 | - | - | Jan 31, 2024 |
| Northern Lights Fund Trust | 0.00% | 470 | - | - | Jan 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 1,273 | - | - | Dec 31, 2023 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 9,341 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 16 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 1,004 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 5,033 | -5,000 | -49.84% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 33,615 | 243 | 0.73% | Feb 29, 2024 |
| PIMCO Equity Series | 0.00% | 451 | 37 | 8.94% | Mar 31, 2024 |
CRISPR Therapeutics's largest mutual fund holder by % of total assets is "Alger ETF Trust", owning 4.57K shares, compromising 0.64% of its total assets.
CRISPR Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 267 | -48.26% |
| 31 Mar, 24 | 516 | 0.58% |
| 31 Dec, 23 | 513 | 17.93% |
| 30 Sep, 23 | 435 | -3.33% |
| 30 Jun, 23 | 450 | 11.39% |
| 31 Mar, 23 | 404 | -4.72% |
| 31 Dec, 22 | 424 | -8.23% |
| 30 Sep, 22 | 462 | 0.87% |
| 30 Jun, 22 | 458 | -2.14% |
| 31 Mar, 22 | 468 | -1.89% |
| 31 Dec, 21 | 477 | -5.36% |
| 30 Sep, 21 | 504 | -6.67% |
| 30 Jun, 21 | 540 | 13.92% |
| 31 Mar, 21 | 474 | 7.24% |
| 31 Dec, 20 | 442 | 35.17% |
| 30 Sep, 20 | 327 | 10.10% |
| 30 Jun, 20 | 297 | 8.39% |
| 31 Mar, 20 | 274 | -0.36% |
| 31 Dec, 19 | 275 | 38.89% |
| 30 Sep, 19 | 198 | -0.50% |
| 30 Jun, 19 | 199 | 8.74% |
| 31 Mar, 19 | 183 | 10.24% |
| 31 Dec, 18 | 166 | -16.16% |
| 30 Sep, 18 | 198 | 7.03% |
| 30 Jun, 18 | 185 | 32.14% |
| 31 Mar, 18 | 140 | 66.67% |
| 31 Dec, 17 | 84 | 33.33% |
| 30 Sep, 17 | 63 | 57.50% |
| 30 Jun, 17 | 40 | 14.29% |
| 31 Mar, 17 | 35 | 34.62% |
| 31 Dec, 16 | 26 | - |
| 31 Mar, 16 | 1 | - |
| 30 Sep, 11 | 1 | - |
| 30 Jun, 10 | 1 | - |
| 31 Mar, 87 | 1 | - |
As of 30 Jun 24, 267 institutions are holding CRISPR Therapeutics's shares, representing a decrease of -48.26% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 22,352,654 | -61.79% |
| 31 Mar, 24 | 58,503,024 | 5.59% |
| 31 Dec, 23 | 55,407,278 | 1.91% |
| 30 Sep, 23 | 54,371,001 | 0.43% |
| 30 Jun, 23 | 54,137,718 | -3.61% |
| 31 Mar, 23 | 56,163,604 | 1.25% |
| 31 Dec, 22 | 55,467,680 | -1.99% |
| 30 Sep, 22 | 56,593,324 | 1.93% |
| 30 Jun, 22 | 55,520,602 | 8.73% |
| 31 Mar, 22 | 51,062,818 | 19.19% |
| 31 Dec, 21 | 42,842,519 | 6.07% |
| 30 Sep, 21 | 40,391,204 | -0.35% |
| 30 Jun, 21 | 40,531,938 | -5.72% |
| 31 Mar, 21 | 42,991,852 | -8.90% |
| 31 Dec, 20 | 47,190,254 | -1.39% |
| 30 Sep, 20 | 47,857,047 | 21.76% |
| 30 Jun, 20 | 39,303,183 | 10.77% |
| 31 Mar, 20 | 35,481,929 | 12.09% |
| 31 Dec, 19 | 31,653,622 | 15.01% |
| 30 Sep, 19 | 27,523,483 | 0.13% |
| 30 Jun, 19 | 27,487,508 | 5.76% |
| 31 Mar, 19 | 25,989,450 | 17.70% |
| 31 Dec, 18 | 22,080,460 | -3.37% |
| 30 Sep, 18 | 22,851,313 | 23.63% |
| 30 Jun, 18 | 18,483,046 | -1.22% |
| 31 Mar, 18 | 18,711,987 | 49.70% |
| 31 Dec, 17 | 12,499,522 | 24.31% |
| 30 Sep, 17 | 10,055,510 | 3.67% |
| 30 Jun, 17 | 9,699,337 | 0.07% |
| 31 Mar, 17 | 9,692,866 | -1.43% |
| 31 Dec, 16 | 9,833,888 | - |
| 31 Mar, 16 | 40 | - |
| 30 Sep, 11 | 12,071 | - |
| 30 Jun, 10 | 1,025 | - |
| 31 Mar, 87 | 8,192 | - |
CRISPR Therapeutics (CRSP) has 22.35M shares outstanding as of 30 Jun 24, down -61.79% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 27.33% | 0.53% |
| 31 Mar, 24 | 71.52% | 1.48% |
| 31 Dec, 23 | 69.53% | 1.48% |
| 30 Sep, 23 | 68.47% | 1.46% |
| 30 Jun, 23 | 68.45% | 1.34% |
| 31 Mar, 23 | 71.39% | 1.42% |
| 31 Dec, 22 | 70.81% | 1.34% |
| 30 Sep, 22 | 72.63% | 1.41% |
| 30 Jun, 22 | 71.70% | 1.63% |
| 31 Mar, 22 | 66.23% | 2.08% |
| 31 Dec, 21 | 56.41% | 2.00% |
| 30 Sep, 21 | 53.05% | 1.86% |
| 30 Jun, 21 | 53.45% | 1.62% |
| 31 Mar, 21 | 57.37% | 1.12% |
| 31 Dec, 20 | 71.55% | 1.53% |
| 30 Sep, 20 | 68.34% | 1.66% |
| 30 Jun, 20 | 64.14% | 1.87% |
| 31 Mar, 20 | 58.52% | 1.92% |
| 31 Dec, 19 | 55.15% | 2.19% |
| 30 Sep, 19 | 50.20% | 1.88% |
| 30 Jun, 19 | 51.68% | 2.08% |
| 31 Mar, 19 | 49.89% | 2.71% |
| 31 Dec, 18 | 42.87% | 1.84% |
| 30 Sep, 18 | 48.22% | 3.10% |
| 30 Jun, 18 | 39.46% | 2.37% |
| 31 Mar, 18 | 40.79% | 5.49% |
| 31 Dec, 17 | 27.25% | 4.33% |
| 30 Sep, 17 | 25.08% | 4.24% |
| 30 Jun, 17 | 24.31% | 4.08% |
| 31 Mar, 17 | 24.40% | 3.98% |
| 31 Dec, 16 | 24.76% | - |
| 31 Mar, 16 | 0.00% | - |
| 30 Sep, 11 | 0.04% | - |
| 30 Jun, 10 | 0.00% | - |
| 31 Mar, 87 | 0.03% | - |
As of 30 Jun 24, CRISPR Therapeutics is held by 27.33% institutional shareholders, representing a 0.53% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 116 | -50.00% |
| 31 Mar, 24 | 232 | -11.11% |
| 31 Dec, 23 | 261 | 31.82% |
| 30 Sep, 23 | 198 | 18.56% |
| 30 Jun, 23 | 167 | 12.08% |
| 31 Mar, 23 | 149 | -13.37% |
| 31 Dec, 22 | 172 | -8.02% |
| 30 Sep, 22 | 187 | - |
| 30 Jun, 22 | 187 | -21.76% |
| 31 Mar, 22 | 239 | 0.42% |
| 31 Dec, 21 | 238 | -3.25% |
| 30 Sep, 21 | 246 | -14.88% |
| 30 Jun, 21 | 289 | 1.76% |
| 31 Mar, 21 | 284 | 5.19% |
| 31 Dec, 20 | 270 | 61.68% |
| 30 Sep, 20 | 167 | 6.37% |
| 30 Jun, 20 | 157 | 9.03% |
| 31 Mar, 20 | 144 | -10.00% |
| 31 Dec, 19 | 160 | 97.53% |
| 30 Sep, 19 | 81 | -10.00% |
| 30 Jun, 19 | 90 | 7.14% |
| 31 Mar, 19 | 84 | 16.67% |
| 31 Dec, 18 | 72 | -23.40% |
| 30 Sep, 18 | 94 | -24.80% |
| 30 Jun, 18 | 125 | 30.21% |
| 31 Mar, 18 | 96 | 71.43% |
| 31 Dec, 17 | 56 | 43.59% |
| 30 Sep, 17 | 39 | 160.00% |
| 30 Jun, 17 | 15 | -34.78% |
| 31 Mar, 17 | 23 | -11.54% |
| 31 Dec, 16 | 26 | - |
| 31 Mar, 16 | 1 | - |
| 30 Sep, 11 | 1 | - |
| 30 Jun, 10 | 1 | - |
| 31 Mar, 87 | 1 | - |
116 institutional shareholders have increased their position in CRSP stock as of 30 Jun 24 compared to 232 in the previous quarter (a -50.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 69 | -51.41% |
| 31 Mar, 24 | 142 | 16.39% |
| 31 Dec, 23 | 122 | 14.02% |
| 30 Sep, 23 | 107 | -20.15% |
| 30 Jun, 23 | 134 | 13.56% |
| 31 Mar, 23 | 118 | -6.35% |
| 31 Dec, 22 | 126 | 5.88% |
| 30 Sep, 22 | 119 | -4.80% |
| 30 Jun, 22 | 125 | 26.26% |
| 31 Mar, 22 | 99 | -23.26% |
| 31 Dec, 21 | 129 | 8.40% |
| 30 Sep, 21 | 119 | -4.03% |
| 30 Jun, 21 | 124 | 27.84% |
| 31 Mar, 21 | 97 | 4.30% |
| 31 Dec, 20 | 93 | 8.14% |
| 30 Sep, 20 | 86 | 40.98% |
| 30 Jun, 20 | 61 | 8.93% |
| 31 Mar, 20 | 56 | 7.69% |
| 31 Dec, 19 | 52 | -1.89% |
| 30 Sep, 19 | 53 | 43.24% |
| 30 Jun, 19 | 37 | -5.13% |
| 31 Mar, 19 | 39 | -11.36% |
| 31 Dec, 18 | 44 | 2.33% |
| 30 Sep, 18 | 43 | 38.71% |
| 30 Jun, 18 | 31 | 19.23% |
| 31 Mar, 18 | 26 | 116.67% |
| 31 Dec, 17 | 12 | 140.00% |
| 30 Sep, 17 | 5 | -37.50% |
| 30 Jun, 17 | 8 | 166.67% |
| 31 Mar, 17 | 3 | - |
| 31 Dec, 16 | - | - |
| 31 Mar, 16 | - | - |
| 30 Sep, 11 | - | - |
| 30 Jun, 10 | - | - |
| 31 Mar, 87 | - | - |
69 institutional shareholders have reduced their position in CRSP stock as of 30 Jun 24 compared to 142 in the previous quarter (a -51.41% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 267 | -48.26% | 22,352,654 | -61.79% | 27.33% | 0.53% | 116 | -50.00% | 69 | -51.41% |
| 31 Mar, 24 | 516 | 0.58% | 58,503,024 | 5.59% | 71.52% | 1.48% | 232 | -11.11% | 142 | 16.39% |
| 31 Dec, 23 | 513 | 17.93% | 55,407,278 | 1.91% | 69.53% | 1.48% | 261 | 31.82% | 122 | 14.02% |
| 30 Sep, 23 | 435 | -3.33% | 54,371,001 | 0.43% | 68.47% | 1.46% | 198 | 18.56% | 107 | -20.15% |
| 30 Jun, 23 | 450 | 11.39% | 54,137,718 | -3.61% | 68.45% | 1.34% | 167 | 12.08% | 134 | 13.56% |
| 31 Mar, 23 | 404 | -4.72% | 56,163,604 | 1.25% | 71.39% | 1.42% | 149 | -13.37% | 118 | -6.35% |
| 31 Dec, 22 | 424 | -8.23% | 55,467,680 | -1.99% | 70.81% | 1.34% | 172 | -8.02% | 126 | 5.88% |
| 30 Sep, 22 | 462 | 0.87% | 56,593,324 | 1.93% | 72.63% | 1.41% | 187 | - | 119 | -4.80% |
| 30 Jun, 22 | 458 | -2.14% | 55,520,602 | 8.73% | 71.70% | 1.63% | 187 | -21.76% | 125 | 26.26% |
| 31 Mar, 22 | 468 | -1.89% | 51,062,818 | 19.19% | 66.23% | 2.08% | 239 | 0.42% | 99 | -23.26% |
| 31 Dec, 21 | 477 | -5.36% | 42,842,519 | 6.07% | 56.41% | 2.00% | 238 | -3.25% | 129 | 8.40% |
| 30 Sep, 21 | 504 | -6.67% | 40,391,204 | -0.35% | 53.05% | 1.86% | 246 | -14.88% | 119 | -4.03% |
| 30 Jun, 21 | 540 | 13.92% | 40,531,938 | -5.72% | 53.45% | 1.62% | 289 | 1.76% | 124 | 27.84% |
| 31 Mar, 21 | 474 | 7.24% | 42,991,852 | -8.90% | 57.37% | 1.12% | 284 | 5.19% | 97 | 4.30% |
| 31 Dec, 20 | 442 | 35.17% | 47,190,254 | -1.39% | 71.55% | 1.53% | 270 | 61.68% | 93 | 8.14% |
| 30 Sep, 20 | 327 | 10.10% | 47,857,047 | 21.76% | 68.34% | 1.66% | 167 | 6.37% | 86 | 40.98% |
| 30 Jun, 20 | 297 | 8.39% | 39,303,183 | 10.77% | 64.14% | 1.87% | 157 | 9.03% | 61 | 8.93% |
| 31 Mar, 20 | 274 | -0.36% | 35,481,929 | 12.09% | 58.52% | 1.92% | 144 | -10.00% | 56 | 7.69% |
| 31 Dec, 19 | 275 | 38.89% | 31,653,622 | 15.01% | 55.15% | 2.19% | 160 | 97.53% | 52 | -1.89% |
| 30 Sep, 19 | 198 | -0.50% | 27,523,483 | 0.13% | 50.20% | 1.88% | 81 | -10.00% | 53 | 43.24% |
| 30 Jun, 19 | 199 | 8.74% | 27,487,508 | 5.76% | 51.68% | 2.08% | 90 | 7.14% | 37 | -5.13% |
| 31 Mar, 19 | 183 | 10.24% | 25,989,450 | 17.70% | 49.89% | 2.71% | 84 | 16.67% | 39 | -11.36% |
| 31 Dec, 18 | 166 | -16.16% | 22,080,460 | -3.37% | 42.87% | 1.84% | 72 | -23.40% | 44 | 2.33% |
| 30 Sep, 18 | 198 | 7.03% | 22,851,313 | 23.63% | 48.22% | 3.10% | 94 | -24.80% | 43 | 38.71% |
| 30 Jun, 18 | 185 | 32.14% | 18,483,046 | -1.22% | 39.46% | 2.37% | 125 | 30.21% | 31 | 19.23% |
| 31 Mar, 18 | 140 | 66.67% | 18,711,987 | 49.70% | 40.79% | 5.49% | 96 | 71.43% | 26 | 116.67% |
| 31 Dec, 17 | 84 | 33.33% | 12,499,522 | 24.31% | 27.25% | 4.33% | 56 | 43.59% | 12 | 140.00% |
| 30 Sep, 17 | 63 | 57.50% | 10,055,510 | 3.67% | 25.08% | 4.24% | 39 | 160.00% | 5 | -37.50% |
| 30 Jun, 17 | 40 | 14.29% | 9,699,337 | 0.07% | 24.31% | 4.08% | 15 | -34.78% | 8 | 166.67% |
| 31 Mar, 17 | 35 | 34.62% | 9,692,866 | -1.43% | 24.40% | 3.98% | 23 | -11.54% | 3 | - |
| 31 Dec, 16 | 26 | - | 9,833,888 | - | 24.76% | - | 26 | - | - | - |
| 31 Mar, 16 | 1 | - | 40 | - | 0.00% | - | 1 | - | - | - |
| 30 Sep, 11 | 1 | - | 12,071 | - | 0.04% | - | 1 | - | - | - |
| 30 Jun, 10 | 1 | - | 1,025 | - | 0.00% | - | 1 | - | - | - |
| 31 Mar, 87 | 1 | - | 8,192 | - | 0.03% | - | 1 | - | - | - |
CRISPR Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of CRISPR Therapeutics's stock was made by Kulkarni Samarth on Aug 12 2024, selling 100,000 shares at - per share (valued at -).
CRISPR Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 13 | 17 | 76.47% |
| Q1 2024 | 20 | 26 | 76.92% |
| Q4 2023 | 6 | - | - |
| Q2 2023 | 11 | 9 | 122.22% |
| Q1 2023 | 18 | 24 | 75.00% |
| Q4 2022 | 13 | 18 | 72.22% |
| Q3 2022 | 9 | 15 | 60.00% |
| Q2 2022 | 15 | 4 | 375.00% |
| Q1 2022 | 14 | 12 | 116.67% |
| Q4 2021 | 17 | 8 | 212.50% |
| Q3 2021 | 5 | 19 | 26.32% |
| Q2 2021 | 16 | 47 | 34.04% |
| Q1 2021 | 41 | 69 | 59.42% |
| Q4 2020 | 15 | 67 | 22.39% |
| Q3 2020 | 16 | 38 | 42.11% |
| Q2 2020 | 13 | 34 | 38.24% |
| Q1 2020 | 11 | 2 | 550.00% |
| Q4 2019 | 10 | 13 | 76.92% |
| Q3 2019 | 5 | 8 | 62.50% |
| Q2 2019 | 8 | 7 | 114.29% |
13 total buy trades, and 17 total sell trades (buy/sell ratio of 0.76%) were made by CRISPR Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 2 | - |
| Q1 2024 | - | 15 | - |
| Q4 2023 | - | - | - |
| Q2 2023 | - | 6 | - |
| Q1 2023 | - | 7 | - |
| Q4 2022 | - | 9 | - |
| Q3 2022 | - | 10 | - |
| Q2 2022 | - | 2 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 12 | - |
| Q2 2021 | - | 38 | - |
| Q1 2021 | - | 38 | - |
| Q4 2020 | - | 55 | - |
| Q3 2020 | - | 22 | - |
| Q2 2020 | - | 25 | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | 7 | - |
| Q3 2019 | - | 3 | - |
| Q2 2019 | - | 3 | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of CRISPR Therapeutics's stocks.
CRISPR Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| CWBR | CohBar, Inc. |
| FATE | Fate Therapeutics, Inc. |
| REGN | Regeneron Pharmaceuticals, Inc. |
| SRPT | Sarepta Therapeutics, Inc. |
| NTLA | Intellia Therapeutics, Inc. |
| EDIT | Editas Medicine, Inc. |
| VERV | Verve Therapeutics, Inc. |
| AVRO | AVROBIO, Inc. |
| CRBU | Caribou Biosciences, Inc. |
| KRYS | Krystal Biotech, Inc. |
| NVO | Novo Nordisk A/S |
| BEAM | Beam Therapeutics Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
CRSP Ownership FAQ
Who Owns CRISPR Therapeutics?
CRISPR Therapeutics is owned by institutional shareholders (27.33%), insiders (1.74%), and public (70.93%). The largest institutional shareholder of CRISPR Therapeutics is CAPITAL INTERNATIONAL INVESTORS (9.62% of total shares) and the top mutual fund owner is Alger ETF Trust (0.64% of total shares).
Who are the major institutional shareholders of CRISPR Therapeutics?
CRISPR Therapeutics's major institutional shareholders are CAPITAL INTERNATIONAL INVESTORS, ARK INVESTMENT MANAGEMENT LLC, SUMITOMO MITSUI TRUST HOLDINGS, INC., NIKKO ASSET MANAGEMENT AMERICAS, INC., and BLACKROCK INC.. The top five shareholders own together 30.23% of the company's share outstanding.
How many CRISPR Therapeutics shareholders are there?
As of Jun 2024, there are 267 institutional shareholders of CRISPR Therapeutics.
What percentage of CRISPR Therapeutics is owned by CAPITAL INTERNATIONAL INVESTORS?
CAPITAL INTERNATIONAL INVESTORS owns 7.87M shares of CRISPR Therapeutics, representing 9.62% of the company's total shares outstanding, valued at $424.8M (as of Jun 2024).
What percentage of CRISPR Therapeutics is owned by ARK INVESTMENT MANAGEMENT LLC?
As of Jun 2024, ARK INVESTMENT MANAGEMENT LLC holds 7.78M shares of CRISPR Therapeutics (CRSP), compromising 9.51% of the company, valued at $420.12M.
What percentage of CRISPR Therapeutics is owned by SUMITOMO MITSUI TRUST HOLDINGS, INC?
SUMITOMO MITSUI TRUST HOLDINGS, INC is the third largest holder of CRISPR Therapeutics. The company owns 3.15M of the company's shares outstanding (worth $170.21M).